SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Momenta Pharmaceuticals Inc.
An SI Board Since March 2004
Posts SubjectMarks Bans Symbol
3027 64 0 MNTA
Emcee:  michael_f_murphy Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
1752<i>Did you notice the word "generally?"</i> The word <DewDiligence_on_SI-5/11/2008
1751Did you notice the word "generally?"Robohogs-5/11/2008
1750<i>>Euro drug prices generally are lower for mainline drugs and more exDewDiligence_on_SI-5/11/2008
1749Euro drug prices generally are lower for mainline drugs and more expensive for gRobohogs-5/11/2008
1748>>Nor is it especially newsworthy that the EMEA wants clinical trials to sIRWIN JAMES FRANKEL-5/11/2008
1747deletedIRWIN JAMES FRANKEL-5/11/2008
1746<i>>How can this be viewed as anything but neg for MNTA<</i> DewDiligence_on_SI-5/11/2008
1745Yes, that's what BS had in mind, isn't it?tom pope-5/11/2008
1744How can this be viewed as anything but neg for MNTAosofun-5/11/2008
1743<b> Price of Heparin Has Doubled Since Recall </b> usatoday.com &gDewDiligence_on_SI-5/9/2008
1742Some EU countries still have branded generics that require non-trivial detailingDewDiligence_on_SI-5/9/2008
1741Bear Stearns * An update was recently posted to the EMEA website. The BMWP worrkrw-5/9/2008
1740Who they heck are they to talk???!!! Here's my VALUATION on BSC, $2 a sharGo Market Go!-5/8/2008
1739Bear Stearns. Momenta Pharmaceuticals MNTA–$13.98–Peer Perform DOWNGRADING TOrkrw-5/8/2008
1738Momenta Pharmaceuticals Reports Financial Results for the First Quarter of 2008 mopgcw-5/7/2008
1737Odds and ends from Monday’s DB webcast: siliconinvestor.comDewDiligence_on_SI-5/6/2008
1736Musings on valuation (table): siliconinvestor.com Anyone else?DewDiligence_on_SI-5/1/2008
1735Generic-Lovenox discussion from WPI CC today (29.40 time point): biz.yahoo.com DewDiligence_on_SI-5/1/2008
1734>> I think the wild card is the possibility another generic gets approved IRWIN JAMES FRANKEL-5/1/2008
1733I don't think it would make a ton of difference. Maybe Sandoz could take therkrw-5/1/2008
1732Maybe there's still an edge in the marketing? Since MNTA has been able to ctuck-5/1/2008
1731For case 1 I think the wild card is the possibility another generic gets approrkrw-5/1/2008
1730The comment on the low likelihood of an AG is ij’s, not mine. In msg #1728, my cDewDiligence_on_SI-5/1/2008
1729There's another minor wild card in here - the status of the patent appeal. BBiomaven-4/30/2008
1728Considering the recent news I am revising my valuation estimates. I raise the chIRWIN JAMES FRANKEL-4/30/2008
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News